GET THE LATEST UPDATES
Receive the latest event information about key speakers, sponsorship opportunities and exhibiting.
November 9-11, 2020 | Virtual Conference
Dr. Tao Bai is a Lead Pharmacologist and a Team Leader in Office of Bioequivalence (OB) in Office of Generic Drugs (OGD). In her current role, she coordinates all COVID-19 related scientific inquiries submitted to OGD and provide her professional input to ensure an efficient and consistent response to these inquiries in a timely fashion. Prior to joining FDA in 2010, Dr. Bai was a postdoctoral Research Fellow at University of Maryland School of Pharmacy studying Nasal and Inhalation Drug Products. She received her Ph.D. in Pharmaceutical Sciences from University of Maryland.